Arcus Biosciences Inc (NYSE:RCUS)

20.29
Delayed Data
As of Jun 01
 -0.01 / -0.05%
Today’s Change
15.70
Today|||52-Week Range
36.13
-1.89%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$1.6B

Company Description

Arcus Biosciences, Inc. engages in the development and commercialization of immunotherapies. It competes in the segments of the pharmaceutical, biotechnology and other related markets that develop immunotherapies for the treatment of cancer. The company was founded by Terry J. Rosen and Juan Carlos Jaen in 2015 and is headquartered in Hayward, CA.

Contact Information

Arcus Biosciences, Inc.
3928 Point Eden Way
Hayward California 94545
P:(510) 694-6200
Investor Relations:

Employees

Shareholders

Individual stakeholders47.23%
Mutual fund holders43.20%
Other institutional27.48%

Top Executives

Terry J. RosenChairman & Chief Executive Officer
Juan Carlos JaenPresident & Director
Jennifer A. JarrettChief Operating Officer & Director
Robert C. GoeltzChief Financial Officer
Steve YoungSenior VP-Technology & Quantitative Biology